Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Lobo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Seminars in Respiratory and Critical Care Medicine|April 1, 2015
Primary ciliary dyskinesiaJason Lobo, Maimoona A Zariwala, Peadar G Noone
Clinics in Chest Medicine|May 30, 2012
Recent advances in cystic fibrosisJason Lobo, Juan M Rojas-Balcazar, Peadar G Noone
Chest|February 23, 2010
Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumoniaL Jason Lobo, Kurt D Reed, Richard G Wunderink
Transplantation|April 10, 2015
Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung TransplantationLeonard Jason Lobo, Zeynep Tulu, Robert M Aris, et al.
Pharmacotherapy|June 11, 2022
Poor tolerability of cystic fibrosis transmembrane conductance regulator modulator therapy in lung transplant recipientsChristina Teeter Doligalski, Cameron J McKinzie, Anita Yang, et al.
Clinical Transplantation|July 8, 2022
Pharmacotherapy of chronic lung allograft dysfunction post lung transplantationRickey A Evans, Krysta S Walter, Leonard Jason Lobo, et al.
Journal of Thoracic Disease|January 7, 2022
Donation after circulatory death donors in lung transplantationThomas M Egan, Benjamin E Haithcock, Jason Lobo, et al.
BMC Pulmonary Medicine|September 28, 2024
Design and baseline characteristics of the ILD-PRO registry in patients with progressive pulmonary fibrosisL Jason Lobo, Yi Liu, Peide Li, et al.
Respiratory Research|January 25, 2024
Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO RegistryRoss Summer, Jamie L Todd, Megan L Neely, et al.
Nature Communications|November 28, 2024
Use of epigenetically modified bacteriophage and dual beta-lactams to treat a Mycobacterium abscessus sternal wound infectionMadison Cristinziano, Elena Shashkina, Liang Chen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Seminars in Respiratory and Critical Care Medicine|April 1, 2015
Primary ciliary dyskinesiaJason Lobo, Maimoona A Zariwala, Peadar G Noone
Clinics in Chest Medicine|May 30, 2012
Recent advances in cystic fibrosisJason Lobo, Juan M Rojas-Balcazar, Peadar G Noone
Chest|February 23, 2010
Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumoniaL Jason Lobo, Kurt D Reed, Richard G Wunderink
Transplantation|April 10, 2015
Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung TransplantationLeonard Jason Lobo, Zeynep Tulu, Robert M Aris, et al.
Pharmacotherapy|June 11, 2022
Poor tolerability of cystic fibrosis transmembrane conductance regulator modulator therapy in lung transplant recipientsChristina Teeter Doligalski, Cameron J McKinzie, Anita Yang, et al.
Clinical Transplantation|July 8, 2022
Pharmacotherapy of chronic lung allograft dysfunction post lung transplantationRickey A Evans, Krysta S Walter, Leonard Jason Lobo, et al.
Journal of Thoracic Disease|January 7, 2022
Donation after circulatory death donors in lung transplantationThomas M Egan, Benjamin E Haithcock, Jason Lobo, et al.
BMC Pulmonary Medicine|September 28, 2024
Design and baseline characteristics of the ILD-PRO registry in patients with progressive pulmonary fibrosisL Jason Lobo, Yi Liu, Peide Li, et al.
Respiratory Research|January 25, 2024
Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO RegistryRoss Summer, Jamie L Todd, Megan L Neely, et al.
Nature Communications|November 28, 2024
Use of epigenetically modified bacteriophage and dual beta-lactams to treat a Mycobacterium abscessus sternal wound infectionMadison Cristinziano, Elena Shashkina, Liang Chen, et al.
Pageof 1